Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 1:00 pm Purchase | 2024-12-31 | 13G | Fennec Pharmaceuticals Inc. FENC | Solas Capital Management LLC | 2,250,919 8.200% | 327,383 (+17.02%) | Filing History |
| 2025-02-14 12:06 pm Sale | 2024-12-31 | 13G | Fennec Pharmaceuticals Inc. FENC | DG Capital Management LLC | 1,114,692 4.100% | -407,512 (-26.77%) | Filing History |
| 2024-11-14 1:58 pm Purchase | 2024-09-30 | 13G | Fennec Pharmaceuticals Inc. FENC | Solas Capital Management LLC | 1,923,536 7.000% | 545,023 (+39.54%) | Filing History |
| 2024-11-12 7:38 pm Purchase | 2024-09-30 | 13G | Fennec Pharmaceuticals Inc. FENC | DG Capital Management LLC | 1,522,204 5.500% | 105,748 (+7.47%) | Filing History |
| 2024-06-27 4:43 pm Purchase | 2024-05-14 | 13G | Fennec Pharmaceuticals Inc. FENC | DG Capital Management LLC | 1,416,456 5.200% | 1,416,456 (New Position) | Filing History |
| 2024-02-14 10:47 am Purchase | 2023-12-31 | 13G | Fennec Pharmaceuticals Inc. FENC | Solas Capital Management LLC | 1,378,513 5.200% | 1,378,513 (New Position) | Filing History |
| 2023-02-14 3:35 pm Purchase | 2022-12-31 | 13G | Fennec Pharmaceuticals Inc. FENC | Sonic GP LLC | 2,578,134 9.800% | 2,578,134 (New Position) | Filing History |
| 2022-02-14 09:08 am Sale | 2021-12-31 | 13G | Fennec Pharmaceuticals Inc. FENC | Sonic Fund II L.P. | 2,469,880 9.500% | -25,873 (-1.04%) | Filing History |
| 2022-02-11 10:08 am Sale | 2021-12-31 | 13G | Fennec Pharmaceuticals Inc. FENC | Avoro Capital Advisors LLC | 1,200,000 4.600% | -470,000 (-28.14%) | Filing History |
| 2021-02-16 3:44 pm Purchase | 2020-04-30 | 13G | Fennec Pharmaceuticals Inc. FENC | Sonic Fund II L.P. | 2,495,753 9.700% | 2,495,753 (New Position) | Filing History |
| 2021-02-12 4:00 pm Purchase | 2020-12-31 | 13G | Fennec Pharmaceuticals Inc. FENC | Southpoint Capital Advisors LP | 4,077,214 15.800% | 80,000 (+2.00%) | Filing History |
| 2021-02-12 08:01 am Purchase | 2020-12-31 | 13G | Fennec Pharmaceuticals Inc. FENC | Avoro Capital Advisors LLC | 1,670,000 6.500% | 564,001 (+50.99%) | Filing History |
| 2020-05-04 5:22 pm Purchase | 2020-04-30 | 13D | Fennec Pharmaceuticals Inc. FENC | Essetifin SPA | 3,993,694 16.200% | 768,000 (+23.81%) | Filing History |